[Diffusion-weighted magnetic resonance imaging instead of contrast-enhanced imaging for evaluating immediate therapeutic efficacy of high-intensity focused ultrasound ablation of adenomyosis].

Y Cui, Lihong Yao, L Yao, Meiyan Feng, M Feng, J Zhang, D Zhang
Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021 · vol. 41(10) , pp. 1583–1587 · doi:10.12122/j.issn.1673-4254.2021.10.19 · PMID:34755676 · PMC8586868 · W3212879267
article OA: green CC0
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

Diffusion-weighted MRI can replace contrast-enhanced MRI for assessing immediate therapeutic efficacy of high-intensity focused ultrasound ablation for adenomyosis, showing good consistency in necrotic volume measurements and reliability.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text ⓘ

This retrospective study evaluated whether diffusion-weighted MRI (DWI) can replace contrast-enhanced MRI for assessing immediate ablation efficacy after high-intensity focused ultrasound (HIFU) in 29 patients with adenomyosis, with MRI performed pre-treatment and within 24 hours post-treatment. Two independent observers classified ablation lesions on DWI into three morphological types and assessed inter- and intra-observer agreement using kappa statistics; they also measured necrotic area volumes for lesion types 2 and 3 and compared DWI-derived volumes with those from contrast-enhanced images using Bland–Altman plots. DWI lesion morphology showed good agreement (kappa up to 0.933), and DWI volume measurements demonstrated good concordance and reliability versus contrast-enhanced measurements, though small type 1 lesions were sometimes not measurable on DWI. The paper does not explicitly discuss limitations beyond the practical finding that smaller, less effective ablation lesions may be difficult to measure on DWI, and it used DWI only for types 2 and 3 volume comparisons. This paper is centrally about adenomyosis—using DWI instead of contrast-enhanced imaging to evaluate immediate HIFU ablation outcomes.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: To explore the feasibility of diffusion-weighted magnetic resonance imaging (DWI) instead of contrast-enhanced (CE) imaging for evaluation of the immediate therapeutic efficacy of high-intensity focused ultrasound (HIFU) ablation for treatment of adenomyosis. METHODS: We retrospectively analyzed the data of 29 patients aged 40.5 ± 5.4 years under going HIFU treatment for adenomyosis in our hospital between December, 2017 and July, 2020. The patients received MRI examination both before and within 24 h after the operation. Two observers analyzed the morphology of the ablation area on DWI and classified the lesions into type 1 (spot-like or no obvious signal intensity changes), type 2 (patchy signal intensity changes) and type 3 (ring-like signal intensity changes). The inter- and intra-observer reliability of morphological assessment was assessed using kappa test. The volume of necrotic tissues following the ablation was measured with both DWI and CE imaging, and the consistency of the measurements and the inter- and intra-observer reliability of DWI-based measurements were evaluated using Bland-Altman plot tests. RESULTS: = 0.000), respectively. Bland-Altman plots showed a good consistency of the necrotic volumes measured by CE and at DWI with a strong inter- and intra-observer reliability of DWI-based volume measurements (with only one point outside the range of 95% limits of agreement). The remaining 4 or 5 lesions, which presented with type 1 signal changes following ablation, were all small in size (the largest was only 18.61 cm3) and showed poor therapeutic responses to the ablation. CONCLUSION: DWI-based morphological assessment and necrotic tissue volume measurement can replace CE imaging for assessment of the immediate therapeutic efficacy of HIFU ablation for treatment of adenomyosis.
Full text 1,105 characters · extracted from oa-doi-fallback · click to expand
南方医科大学学报 ›› 2021, Vol. 41 ›› Issue (10): 1583-1587.doi: 10.12122/j.issn.1673-4254.2021.10.19 崔运能，姚亮凤，冯敏清，张 婧，张大伟 - 南方医科大学附属佛山妇幼保健院放射科，妇科，广东 佛山 528000 CUI Yunneng, YAO Liangfeng, FENG Minqing, ZHANG Jing, ZHANG Dawei - Department of Radiology, Department of Gynecology, Affiliated Foshan Maternity & Child Healthcare Hospital, Southern Medical University (Foshan Maternity & Child Healthcare Hospital）, Foshan 528000, China 摘要： 目的 探讨磁共振成像DWI序列在评估高强度聚焦超声（HIFU）治疗子宫腺肌症即时消融效果中代替增强扫描的可行性。方法 回顾性分析2017年12月~2020年7月在南方医科大学附属佛山妇幼保健院就诊的29例子宫腺肌症患者资料，平均年龄40.5±5.4岁，均于HIFU术前及术后24 h内行MRI检查。由两名观察者独立评估DWI图像上消融灶的形态，分为1型：斑点状或无信号改变，2型：斑片状，3型：环状，通过kappa检验法评估DWI图像上消融灶形态分型的观察者间、观察者内一致性。 在DWI图像上测量2型及3型消融灶的消融坏死区体积，通过Bland-Altman法评估DWI与增强扫描图像上测量消融坏死区体积的一致性、DWI图像上测量消融坏死区体积的观察者间、观察者内的可靠性。结果 29个消融坏死区，体积为36.9（16.4，65.6）cm3, 在DWI上24~25个（82.8%~86.2%）消融灶为可测量的2、3型。在DWI图像，消融灶形态分型的观察者间及观察者内一致性的kappa值分别为0.798（P=0.000）、0.933（P=0.000）。Bland-Altman图显示，DWI与增强扫描图像上测量消融坏死区体积的一致性、DWI图像上测量消融坏死区体积的观察者间、观察者内的可靠性均为良好，均仅有一个点在95%一致性界限范围之外。4~5个无法在DWI图像上测量的1型消融灶的体积较小，最大者仅为18.61 cm3，消融治疗效果欠佳。结论 通过对消融坏死区形态评估、体积测量，DWI序列可评估子宫肌腺症HIFU治疗的即时消融效果，代替增强扫描。

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis High-Intensity Focused Ultrasound Ablation Diffusion Magnetic Resonance Imaging Female Humans Magnetic Resonance Imaging Reproducibility of Results Retrospective Studies

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (15)

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:24:14.728497+00:00
License: CC0 · commercial use OK